MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmj.g130

Медицинская библиотека · BMJ (Clinical research ed.) · 2014

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.

Elfström K Miriam, Smelov Vitaly, Johansson Anna L V, Eklund Carina, Nauclér Pontus, Arnheim-Dahlström Lisen, Dillner Joakim

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

To assess whether the increased sensitivity of screening for human papillomavirus (HPV) may represent overdiagnosis and to compare the long term duration of protective effect against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in HPV based and cytology based screening.

DESIGN

13 year follow-up of the Swedescreen randomised controlled trial of primary HPV screening.

SETTING

Organised cervical screening programme in Sweden.

PARTICIPANTS

12,527 women aged 32-38 attending organised screening were enrolled and randomised to HPV and cytology double testing (intervention arm, n=6257) or to cytology only, with samples frozen for future HPV testing (control arm, n=6270).

MAIN OUTCOME MEASURES: Cumulative incidence of CIN2+ and CIN3+ (Kaplan Meier curves). Longitudinal test characteristics were calculated for cytology only, HPV testing only, and cytology and HPV testing combined, adjusting for censoring.

RESULTS

The increased detection of CIN2+ in the intervention arm decreased over time. After six years, the cumulative incidence of CIN3+ was similar in both trial arms, and after 11 years the cumulative incidence of CIN2+ became similar in both arms. The longitudinal sensitivity of cytology for CIN2+ in the control arm at three years was similar to the sensitivity of HPV testing in the intervention arm at five years of follow-up: 85.94% (95% confidence interval 76.85% to 91.84%) v 86.40% (79.21% to 91.37%). The sensitivity of HPV screening for CIN3+after five years was 89.34% (80.10% to 94.58%) and for cytology after three years was 92.02% (80.59% to 96.97%).

CONCLUSIONS

Over long term follow-up, the cumulative incidence of CIN2+ was the same for HPV screening and for cytology, implying that the increased sensitivity of HPV screening for CIN2+ reflects earlier detection rather than overdiagnosis. The low long term risks of CIN3+ among women who tested negative in HPV screening, support screening intervals of five years for such women.

TRIAL REGISTRATION: Clinicaltrials.gov NCT00479375.

Для цитирования: Elfström K Miriam, Smelov Vitaly, Johansson Anna L V, Eklund Carina, Nauclér Pontus, Arnheim-Dahlström Lisen, Dillner Joakim. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.. BMJ (Clinical research ed.). 2014. DOI: 10.1136/bmj.g130.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.